UC News

Kettering Lab Complex Reopened

headshot of Administrator By Administrator
2 minute read January 10, 2014

The Kettering Lab Complex reopened today (Friday, Jan. 10, 2014) after closing earlier this week as a result of an accidental sprinkler system activation that affected electrical equipment and forced a shutdown of power to the Mid-Wing and North Wing.

Access to the Mid-Wing and possibly parts of the North Wing would remain restricted, Public Safety said, as restoration work continued.

Kettering Lab is home to the Department of Environmental Health.

Shuk-Mei Ho, PhD,  Jacob G. Schmidlapp Chair of Environmental Health, said the complex's atrium, recently converted to work space, was being used as a "rescue area" for paper and electronic equipment. Papers were spread out to dry in the area as Ho led an Academic Health Center public information officer on a impromptu tour of the building this morning.

Ho said the water damage occurred when ice thawed Wednesday, triggering the building's sprinkler system.

If you have questions, please contact Kenneth Bloomer at 513-556-0605.
 

Tags

Related Stories

1

Make Hoxworth Blood Center’s special holiday events part of your family celebrations this December

December 12, 2025

This December, Hoxworth Blood Center, University of Cincinnati, is inviting families across Greater Cincinnati to add something truly meaningful to their holiday traditions: giving the gift of life. With festive community events, beloved local partners and special thank-you gifts for donors, Hoxworth is making it easier, and more heartwarming than ever, to roll up your sleeves and help save lives close to home.

2

Ohio nurses weigh in on proposed federal loan rule

December 12, 2025

Spectrum News journalist Javari Burnett spoke with UC Dean Alicia Ribar and UC nursing students Megan Romero and Nevaeh Haskins about proposed new federal student loan rules. Romero and Haskins, both seniors, were filmed in the College of Nursing’s Simulation Lab.

3

New combination treatment improves multiple myeloma outcomes

December 11, 2025

The University of Cincinnati Cancer Center's Ed Faber, DO, provided commentary to Medscape on the COBRA study that found the combination of carfilzomib combined with lenalidomide and dexamethasone (KRd) shows significantly greater efficacy than the previous standard of care.